ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Wacker Scores German Biopharma Maker

by Alex Scott
November 18, 2013 | APPEARED IN VOLUME 91, ISSUE 46

Wacker Chemie ,a Munich-based chemical company, has agreed to acquire Scil Proteins Production, a Halle, Germany-based manufacturer of engineered proteins for the biopharmaceutical sector, from BioNet Ventures, a private equity firm. The acquisition includes a suite of technology patents and a production site with 1,500 L of Good Manufacturing Practices fermentation capacity. The deal will enable Wacker to meet the requirements of its Biosolutions business customers as their projects move to commercial production, Wacker says. The firm plans to retain all 80 Scil staffers.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment